Literature DB >> 22198440

Comparison of academic and nonacademic sites in multi-center clinical trials.

Christina M Dording1, Elizabeth D Dalton, Michael J Pencina, Maurizio Fava, David Mischoulon.   

Abstract

The selection of appropriate subjects is a critical element of successful clinical trials. Failure to properly identify, select, and retain subjects in clinical trials of antidepressant medications may affect the ability to show separation from placebo. Little is known about which type of site, academic or nonacademic, is superior in selecting and retaining appropriate subjects. In the present investigation, the authors conducted a retrospective analysis comparing the performance of academic and nonacademic sites in selecting and retaining appropriate subjects in a recently completed multi-site clinical study of aripiprazole augmentation. The authors used a set of operationalized criteria called the SAFER to identify appropriate study subjects. No significant differences were found in rates of SAFER interview passing, study completion, and clinical outcomes between academic and nonacademic sites. Our findings suggest that academic and nonacademic sites are equally effective in their ability to identify and retain appropriate study participants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22198440     DOI: 10.1097/JCP.0b013e31823f3b47

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  3 in total

1.  Factors Associated With Time to Site Activation, Randomization, and Enrollment Performance in a Stroke Prevention Trial.

Authors:  Bart M Demaerschalk; Robert D Brown; Gary S Roubin; Virginia J Howard; Eldina Cesko; Kevin M Barrett; Mary E Longbottom; Jenifer H Voeks; Seemant Chaturvedi; Thomas G Brott; Brajesh K Lal; James F Meschia; George Howard
Journal:  Stroke       Date:  2017-08-02       Impact factor: 7.914

2.  Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials.

Authors:  Marlene P Freeman; James Pooley; Martina J Flynn; Lee Baer; David Mischoulon; David Mou; Maurizio Fava
Journal:  J Clin Psychopharmacol       Date:  2017-04       Impact factor: 3.153

3.  Recruitment and retention of participant and study partner dyads in two multinational Alzheimer's disease registration trials.

Authors:  Olivia M Bernstein; Joshua D Grill; Daniel L Gillen
Journal:  Alzheimers Res Ther       Date:  2021-01-08       Impact factor: 6.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.